Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Large Is the Drug Delivery Systems Market Expected to Be in 2029?

The scale of the drug delivery systems market has seen a solid expansion in past years. Its growth is forecasted to rise from $41.17 billion in 2024 to $44.21 billion in 2025, indicating a compound annual growth rate (CAGR) of 7.4%. Factors contributing to this growth during the historical timeline include surging investments in research and development, an increase in chronic illnesses, the emergence of biologics and monoclonal antibodies, a high requirement for non-invasive delivery methods, and an imperative for better patient adherence and compliance.

The market size of drug delivery systems is predicted to experience substantial growth in the coming years, expanding to $58.64 billion in 2029 with a Compound Annual Growth Rate (CAGR) of 7.3%. This growth during the forecast period can be ascribed to the heightened focus on personalized medicine, enlargement of complex and sensitive drug pipelines, an increasing incidence of rare and orphan diseases, supportive regulatory paths for innovative delivery systems, and a rising elderly population. Key trends anticipated in the forecast duration include the creation of nanotechnology-based drug delivery systems, breakthroughs in controlled-release and sustained-release technologies, advancements in biologics and biosimilars needing specialized delivery, the synthesis of smart drug delivery devices, and the development of targeted delivery systems for oncology.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24523&type=smp

What Are The Contributors To Demand In The Drug Delivery Systems Market?

The escalating instances of respiratory issues are predicted to propel the expansion of the drug delivery systems market. With a rising trend in conditions that hinder the smooth operation of the lungs and airways, leading to breathing difficulties and insufficient oxygen intake, respiratory disorders are increasingly common. The continuous exposure of the populace to harmful airborne particles and gases due to growing air pollution is a major cause of these disorders. It harms lung functionality and aids the progression of respiratory ailments. Drug delivery systems are vital for effective treatment of respiratory diseases like asthma, COPD, pulmonary fibrosis, and cystic fibrosis. They assure that the medicine reaches the lungs directly, maximizing the therapeutic effect and minimizing side effects. As per the UK Health Security Agency, a government agency in the UK, there was a 13% surge in tuberculosis cases in England in 2024, numbering 5,480 from the 4,850 cases of 2023. Hence, the rising incidence of respiratory conditions is anticipated to push the growth of the drug delivery systems market.

What Segmentation Categories Are Included In The Drug Delivery Systems Market Analysis?

The drug delivery systems market covered in this report is segmented –

1) By Type: Injection-Based Drug Delivery System, Oral Drug Delivery System, Inhalation Or Pulmonary Drug Delivery System, Transmucosal Drug Delivery System

2) By Material: Polymer-Based Drug Delivery Systems, Lipid-Based Drug Delivery Systems, Inorganic Drug Delivery Systems, Biologics-Based Drug Delivery Systems, Hybrid Drug Delivery Systems

3) By Application: Infectious Disease, Oncology, Ophthalmology, Urology, Diabetes, Central Nervous System, Other Applications

4) By End-User: Hospitals, Pharmaceutical Companies, Research Institutions, Homecare Settings, Diagnostic Laboratories

Subsegments:

1) By Injection-Based Drug Delivery System: Intravenous (IV), Intramuscular (IM), Subcutaneous (SC), Intradermal, Intrathecal, Depot Injections, Needle-Free Injectors

2) By Oral Drug Delivery System: Tablets, Capsules, Solutions And Syrups, Suspensions, Powders And Granules, Modified Release Formulations

3) By Inhalation Or Pulmonary Drug Delivery System: Metered Dose Inhalers (MDIs), Dry Powder Inhalers (DPIs), Nebulizers, Soft Mist Inhalers, Nasal Sprays

4) By Transmucosal Drug Delivery System: Buccal Delivery, Sublingual Delivery, Rectal Delivery, Vaginal Delivery, Nasal Mucosal Delivery

What Upcoming Trends Are Expected To Impact The Drug Delivery Systems Market Globally?

Numerous key players in the drug delivery systems sector are emphasizing novel and innovative creations, such as completely metallic-free, multiple dose nasal spray pumps to enhance user comfort and manageability. These metallic-free multi-dose nasal spray pumps are contraptions designed to dispense several doses of medicine via the nose without incorporating metallic elements, which guarantees safety and compatibility with an array of formulations. For example, Aptar Pharma, a pharmaceutical business headquartered in the United States, introduced the APF Futurity, which is a metal-free, multidose nasal spray pump in January 2023. It is a nasal spray pump specifically designed for the delivery of nasal saline and other comparable over-the-counter products. The product is highly sustainable and it’s the first nasal spray pump from Aptar Pharma to garner Class AA qualification from cyclos-HTP for European recycling schemes. Constructed purely from polyolefin materials and devoid of metal elements or recycling contaminants, it simplifies recycling and enhances recyclate quality. The metal-free pump uses Aptar Pharma’s Advanced Preservative Free technology, for assured accurate and consistent dosage with a mild operation, yet maintaining ease of usage and efficacy.

Who Are The Top-Ranked Companies In The Drug Delivery Systems Market Today?

Major companies operating in the drug delivery systems market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca PLC, Abbott Laboratories Inc., Novartis AG, GlaxoSmithKline PLC, Eli Lilly and Company, Amgen Inc., Becton, Dickinson and Company, Teva Pharmaceutical Industries Ltd., Boston Scientific Corporation, Tandem Diabetes, Pacira Biosciences, Poseida Therapeutics, Universal Stabilization Technologies Inc., Spectrum Pharmaceuticals Inc., VasoRx Inc.

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/drug-delivery-systems-global-market-report

How Is Drug Delivery Systems Market Adoption Varying Across Different Regions And Sectors?

North America was the largest region in the drug delivery system market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the drug delivery systems market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=24523&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model